Notably, these diseases reflect region-specific noradrenergic and serotoninergic insults; in this way, MAO-A and MAO-B dysfunction, and a monoaminergic injury, could participate to a spectrum of symptoms and pathology in both early and sustained AD development [70]. This evidence concerns the gene MAOB and Alzheimer disease.